🔴 MEDPAL AI is trading 5.13% down today as no clear company-specific catalyst was identified

MEDPAL AI is trading 5.13% down now at £3.70, with no clear company-specific catalyst identified.

• Declined from a £3.90 close on August 14, 2026.
• No company-specific announcement dated August 17 or August 14 was identified. The latest listed RNS was the August 11 UK authorisation announcement concerning Eli Lilly’s oral GLP-1 pill; that positive news preceded the decline and does not clearly explain the weakness.
• Trading is closed; no reliable volume or activity data was provided. Broader indices were flat.